AWAU
ABBV icon

Alliance Wealth Advisors (Utah)’s AbbVie ABBV Stock Holding History

Alliance Wealth Advisors (Utah)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08M Sell
8,284
-2,623
-24% -$564K 0.39% 36
2026
Q1 		$2.37M Sell
10,907
-3,879
-26% -$860K 0.51% 33
2025
Q4 		$3.38M Sell
14,786
-5,677
-28% -$1.29M 0.73% 31
2025
Q3 		$4.74M Buy
20,463
+1,122
+6% +$228K 1.11% 17
2025
Q2 		$3.59M Buy
19,341
+766
+4% +$142K 0.86% 34
2025
Q1 		$3.89M Buy
18,575
+535
+3% +$104K 1.02% 25
2024
Q4 		$3.21M Buy
18,040
+480
+3% +$88.3K 0.83% 39
2024
Q3 		$3.47M Buy
17,560
+1,004
+6% +$187K 0.91% 38
2024
Q2 		$2.84M Buy
16,556
+460
+3% +$76.2K 0.83% 40
2024
Q1 		$2.93M Buy
16,096
+18
+0.1% +$3.1K 0.87% 37
2023
Q4 		$2.49M Sell
16,078
-465
-3% -$67.8K 0.84% 37
2023
Q3 		$2.47M Sell
16,543
-1,812
-10% -$266K 0.91% 30
2023
Q2 		$2.47M Buy
18,355
+3,227
+21% +$473K 0.92% 31
2023
Q1 		$2.41M Buy
15,128
+802
+6% +$123K 0.97% 28
2022
Q4 		$2.32M Buy
+14,326
New +$2.2M 1.04% 27

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alliance Wealth Advisors (Utah)'s ABBV Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) reduced its AbbVie (ABBV) stake by 24% in Q2 2026, selling an estimated $564K and leaving 8,284 shares worth $2.08M. The position accounts for 0.39% of the portfolio, ranked #36.

Alliance Wealth Advisors (Utah) first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.74M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alliance Wealth Advisors (Utah) held 8,284 shares of AbbVie worth $2.08M as of Q2 2026.
  • Alliance Wealth Advisors (Utah) sold 2,623 AbbVie shares in Q2 2026, an estimated $564K.
  • AbbVie made up 0.39% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #36 holding.
  • Alliance Wealth Advisors (Utah) first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • Alliance Wealth Advisors (Utah)'s AbbVie position peaked at $4.74M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.